-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师总结如下：CG公布了2026年第一季度喜忧参半的业绩，总资产管理规模（AUM）增长5%至4750亿美元，而收取管理费的资产管理规模仅增长1%至3330亿美元。总收入同比下降28%，已实现的业绩费从去年同期的3.55亿美元大幅下降至6200万美元。我们认为，像CG这样的另类投资公司不应仅凭一个季度的业绩来评判，因为与管理费相关的收益、业绩费、资金流入和变现情况在季度间并不对称。管理层强调，自2024年以来，CG一直是全球IPO募集资金最多的私募股权投资机构，过去两年已募集约100亿美元。尽管管理层未提供具体的2026年业绩指引，且2026年第一季度盈利未达预期，但今年以来，公司发展势头强劲。第一季度资金流入稳健，达130亿美元，过去12个月累计资金流入达525亿美元，这主要得益于全球信贷领域的保险解决方案和资产支持融资策略。投资总额达100亿美元，主要集中在全球信贷领域；已实现收益122亿美元，表明市场退出环境稳定。
Related Articles
Mining & Metals
Canadian Natural Resources Maintained at Hold at TPH After Q1 Results; Price Target at C$70.00
Tudor, Pickering, Holt on Thursday maintained its hold rating on the shares of Canadian Natural Resources (CNQ.TO, CNQ) with a C$70.00 price target following first-quarter results from the country's No.1 oil producer."While generally expected given net debt levels exiting 2025, highlights from the overall update include the formal step-up in return-of-capital alongside the ~4% beat on Q1 cash flow. On Q1 results, headline metrics include C$4.37B AFFO vs. TPHe/Street consensus C$4.19B/C$4.26B (C$2.09/shr vs. TPHe/Street C$2.01/C$2.01), with the delta vs. our model owing to realizations and expenses more than offsetting production. 1,643mboepd came in slightly below TPHe/Street 1,657/1,651, primarily driven by Oil Sands with 275mbopd In Situ comparing to TPHe/Street 279/276 and 588mbopd OSM comparing to TPHe/Street 594/595, though the April run-rate within OSM of 630mbopd bodes well for Q2 (TPHe/Street 587/587). On the balance sheet and return of capital, net debt is now sufficiently below C$16B to have driven CNQ to plan for returning 75% of FCF to shareholders. This is already starting to take effect, with April buybacks already totaling ~$0.3B, matching full Q1's buyback activity ($1.5B in return of capital, consisting of $1.2B in dividends and $0.3B in share repurchases); no change to TPHe H2'27+ at strip for the final uplift to 100% with ND (covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $59.80, Change: $-2.46, Percent Change: -3.95%
$CNQ$CNQ.TO
Insider Trading
Hometrust Bancshares Insider Sold Shares Worth $1,654,419, According to a Recent SEC Filing
Hunter Westbrook, Director, President, CEO, on May 05, 2026, sold 36,096 shares in Hometrust Bancshares (HTB) for $1,654,419. Following the Form 4 filing with the SEC, Westbrook has control over a total of 122,604 common shares of the company, with 105,828 shares held directly and 16,776 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1538263/000153826326000048/xslF345X05/wk-form4_1778166405.xmlPrice: $46.15, Change: $+0.20, Percent Change: +0.42%
$HTB
Asia Markets
European Equities Traded in the US as American Depositary Receipts Heading Lower in Thursday Trading
European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, losing 0.87% to 1,830.89 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and accommodations booking company trivago (TRVG), which advanced 12% and 8%, respectively. They were followed by internet advertising firm Criteo (CRTO) and software company SAP (SAP), which increased 3.8% and 3.5%, respectively.The decliners from continental Europe were led by telecommunications company Nokia (NOK) and petroleum refiner Equinor (EQNR), which fell 4.4% and 4.3%, respectively. They were followed by semiconductor company Sequans Communications (SQNS) and pharmaceutical company Ascendis Pharma (ASND), which were down 2.7% and 2.3% respectively.The gainers from the UK were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which rose 5.3% and 3.8% respectively. They were followed by communications company WPP (WPP) and hospitality company InterContinental Hotels Group (IHG), which were up 2.7% and 2.3% respectively.The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Bicycle Therapeutics (BCYC), which lost 4.9% and 3.2% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and oil and gas company Shell (SHEL), which dropped 2.7% and 2.6% respectively.
$AKTX$ASND$AUTL$BCYC$BDRX$CRTO$EDAP$EQNR$IHG$NOK$SAP$SHEL$SLN$SQNS$TRVG$WPP